# BD expands Holdrege plant to manufacture COVID-19 vaccination syringes

BD is expanding its Holdrege, Nebraska plant with a $70 million investment from a U.S. government partnership to add new manufacturing lines for syringes and needles for pandemic vaccination. The expansion will create up to 45 new jobs, and the plant will produce hundreds of millions of syringes for vaccination use.

- Type: Expansion
- Announced: 2021-01-25
- Where: Holdrege, Nebraska, United States
- Value: $70.0M
- Jobs: 45
- Status: under construction
- Capacity: hundreds of millions of syringes per year
- Products: syringes, needles
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [BD](https://endata.com/companies/20051.md)

## Sources

- [phelpscountyne.com](https://www.phelpscountyne.com/in-the-news/p/item/32455/bd-holdrege-now-hiring-as-it-expands-to-create-covid19-vaccination-devices), 2021-01-25: "The vast majority of the $70 million public/private investment that was announced in July is being invested in Holdrege."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.